Citation Tools
Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
THU0163 Early Response as A Predictor of Long-Term Clinical Response in DMARD-Naïve Patients with Severe, Active and Progressive RA Treated with Certolizumab Pegol plus Optimized MTX versus Optimized MTX Alone
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- THU0163 Early Response as A Predictor of Long-Term Clinical Response in DMARD-Naïve Patients with Severe, Active and Progressive RA Treated with Certolizumab Pegol plus Optimized MTX versus Optimized MTX Alone